表紙
市場調査レポート

疼痛管理用デバイス市場の予測:主要企業の将来の展望

Pain Management Devices Market Forecast 2014-2024: Future Prospects for Leading Companies

発行 Visiongain Ltd 商品コード 306874
出版日 ページ情報 英文 226 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=136.81円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
疼痛管理用デバイス市場の予測:主要企業の将来の展望 Pain Management Devices Market Forecast 2014-2024: Future Prospects for Leading Companies
出版日: 2014年06月26日 ページ情報: 英文 226 Pages
概要

疼痛緩和薬への耐性や依存症の問題を解消する各種技術が成功を収める見通しです。特に神経刺激性デバイスの利用拡大が疼痛管理用デバイス市場全体に大きな恩恵をもたらす因子となっています。

当レポートでは、世界の疼痛管理用デバイスの市場について調査し、デバイスタイプおよび用途(疼痛区分)別の主要動向、主な製品、市場成長予測、主要国市場における動向および成長予測、R&Dパイプラインの動向、主要企業のプロファイルなどを詳細にわたってまとめています。

第1章 レポート概要

第2章 イントロダクション:疼痛および疼痛管理

  • 疼痛:知覚および感情的現象
  • WHOの徐痛ラダー
  • 慢性疼痛の心理社会的影響
  • 疼痛の神経化学
  • 疼痛管理:概要
  • 疼痛管理薬
  • 疼痛管理用デバイス
  • 医療機器の分類
  • 医療機器関連法規制
  • 市場の定義

第3章 世界の疼痛管理用デバイス市場の予測:デバイスタイプ別

  • 世界の疼痛管理市場
  • 疼痛管理用デバイス:世界市場の概要
    • 現在の市場
    • 市場予測
    • 部門別の市場シェアの変化
  • 鎮痛剤注入ポンプ市場の予測
    • 髄腔内投与
    • 患者による自主鎮痛
    • 鎮痛剤注入ポンプ市場の予測
  • 脊髄刺激市場の予測
    • 主要製品
    • 疼痛管理のための脊髄刺激の市場:予測
  • 高周波アブレーション市場の予測
    • 主要製品
    • 市場予測
  • 椎間板内高周波熱凝固(IDET)市場の予測
    • 市場予測
  • 経皮的電気刺激市場の予測
    • 主要製品
    • 市場予測
  • 微弱電流電気神経筋刺激(MENS)市場の予測
    • 市場予測
  • その他の疼痛管理用デバイス市場の予測

第4章 世界の疼痛管理用デバイス市場の予測:用途別

  • 慢性疼痛:さまざまな原因と関連の症状
  • 疼痛管理用デバイス:用途と利用
    • 疼痛管理用デバイス市場:用途別
    • 世界の疼痛管理用デバイス市場の予測:用途別
    • 用途別市場シェアの変化の予測
  • 筋骨格系疼痛管理用デバイス市場の予測
    • 主要製品
    • 市場予測
  • 癌性疼痛管理用デバイス市場の予測
    • 主要製品
    • 市場予測
  • 片頭痛・顔面痛管理用デバイス市場の予測
    • 片頭痛の解消技術
    • 主要製品
    • 市場予測
  • 神経因性疼痛管理用デバイス市場の予測
    • 主要製品
    • 市場予測
  • 外科手術・外傷疼痛管理用デバイス市場の予測
    • 主要製品
    • 市場予測
  • その他の疼痛管理用デバイス市場の予測

第5章 主要国市場の予測

  • 疼痛管理用デバイス市場:地域別
    • 世界における疼痛管理用デバイスの分布
  • 主要国市場の予測
  • 疼痛管理用デバイスの地域別市場:分析・予測
  • 米国:最大の疼痛管理用デバイス市場
  • EU5カ国市場
    • EU5カ国市場:国別の市場シェアの変化
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
  • 中国:技術環境の変化が市場成長を推進
  • 日本:高齢化とオピオイドの中毒性への不安から疼痛管理デバイスの導入を刺激
  • インド:疼痛発症率の拡大と社会経済的環境の改善
  • 韓国:国民健康保険と政府の投資により市場成長を推進
  • ロシア:疼痛デバイスの普及拡大
  • ブラジル:不十分なインフラが成長を制限
  • メキシコ:オピオイド使用の厳しい規制がデバイスの導入を推進
  • その他

第6章 主要企業

  • 疼痛管理用デバイス:多様化した市場
  • BioDelivery Sciences International(BDSI)
  • Boston Scientific
  • Cephalon(Teva Pharmaceuticals)
  • DJO Global(Empi Inc)
  • Endo Pharmaceuticals
  • Hospira
  • Kimberly-Clark Health Care
  • Medtronic
  • Pain Management Technologies Inc
  • St Jude Medical
    • 製品
    • 技術
    • 収益、など

第7章 R&Dパイプライン

  • 末梢神経刺激:パイプライン製品
    • Altius System High Frequency Nerve Block(Neuros Medical)
    • MicroStim System(MicroTransponder Inc)
    • Senza SCS System(Nevro Corporation)
  • 鎮痛剤注入システム:パイプライン製品
    • Programmable Implantable DDS(Palyon Medical Corporation)
    • Zalviso(AcelRx Pharmaceuticals)
  • 後頭神経刺激:パイプライン製品
    • Precision System(Boston Scientific)
  • 高周波アブレーション:パイプライン製品
    • Intracept(Relievant Medsystems Inc)

第8章 定性分析

  • SWOT分析
  • ポーターのファイブフォース分析

第9章 専門家の見解

  • Deepak Kotak博士(BioElectronics)
  • Penney Cowan氏(American American Chronic Pain Association)

第10章 総論

  • 市場概要
  • 疼痛管理用デバイスの商業導入の推進因子
  • 神経調節:高成長の見通し
  • 筋骨格系疼痛殻の需要拡大:市場成長を推進
  • 疼痛管理用デバイスの主要開発事業者
  • 北米・欧州の先進国市場に成長が集中
  • 疼痛管理用デバイスの将来の展望

図表

目次

Pain Management Devices - new study showing you trends, R&D progress, and predicted revenues

Where is the market for pain management devices heading? What are the commercial prospects for this market and related technologies? Visiongain's new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects.

Our 226 page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket and national level. You will see financial results, interviews, trends, opportunities and revenue predictions.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:

  • Dr. Deepak Kotak, Executive Vice President, BioElectronics Corporation
  • Ms Penney Cowan, Chief Executive Officer, The American Chronic Pain Association

You find prospects for key submarkets

In addition to analyses of the overall world market, you see revenue forecasting of seven world-level pain management devices submarkets by device-type to 2024:

  • Spinal cord stimulation market forecast 2014-2024
  • Radiofrequency ablation market forecast 2014-2024
  • Analgesia infusion pumps market forecast 2014-2024
  • Microcurrent electrical neuromuscular stimulation market forecast 2014-2024
  • Intradiscal electrothermal therapy market forecast 2014-2024
  • Transcutaneous electrical nerve stimulation market forecast 2014-2024
  • Others (includes patches) market forecast 2014-2024

Additionally, our new study provides revenue forecasting of six major pain management devices submarkets by application to 2024:

  • Neuropathic pain devices market forecast 2014-2024
  • Cancer pain devices market forecast 2014-2024
  • Surgical & trauma pain devices market forecast 2014-2024
  • Musculoskeletal pain devices market forecast 2014-2024
  • Migraine & facial pain devices market forecast 2014-2024
  • Other applications (includes dental pain and obstetrical pain) pain devices market forecast 2014-2024

Technologies that improve on the tolerance and dependence issues associated with pain relieving drugs will achieve success. The increasing use of neurostimulatory devices, in particular, will be a major benefiting factor for the pain management devices market as a whole.

Our new investigation shows business research and analysis with individual revenue forecasts and discussions. You find dynamics of the industry and assess its potential sales, seeing technologies likely to achieve the most success.

What are the prospects for the leading regions and countries?

In addition to analyses of the overall world market, you will discover individual revenue forecasts for 13 national pain management devices markets to 2024:

  • US
  • Japan
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Brazil
  • Russia
  • India
  • China
  • Mexico
  • South Korea
  • Rest of the World

Regulatory, demographic, and commercial developments worldwide will influence the market, both in the established North American and Western European economies, and the fast-rising emerging markets.

Leading companies and potential for market growth

Our work forecasts the overall world revenue for pain management devices will reach $3,336.5m in 2014. We predict steady growth from 2014 to 2024. Our work shows you which organisations hold the greatest potential. See profiles of 10 leading companies, including these:

  • BioDelivery Sciences International
  • Boston Scientific
  • Cephalon (Teva Pharmaceuticals)
  • DJO Global (Empi Inc)
  • Endo Pharmaceuticals
  • Hospira
  • Kimberly-Clark Healthcare
  • Medtronic
  • Pain Management Inc
  • St Jude Medical

A company profile gives you the following information:

  • Overview of the company, including its history in the market
  • Recent financial results
  • Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures
  • Discussion of a company's activities and outlook including description of leading products

What issues will affect the pain management devices market?

Our new report discusses issues and events affecting the pain management devices market. You will find discussions of many issues and developments, including:

  • Cost savings and efficiencies
  • Overcoming drug tolerance and dependence
  • Understanding pain pathways and mechanisms of action
  • Safety and patient compliance
  • Clinical evidence supporting product efficacy
  • Reimbursement and legislation

Our investigation gives you multi-level business research and analysis with sales forecasts. You see how that industry and market can perform from 2014 to 2024.

How the Pain Management Devices Market Forecast 2014-2024: Opportunities for Leading Companies report helps you

In summary our 226 page report gives you the following knowledge:

  • Revenues to 2024 for the overall world pain management devices market, 7 submarkets by device type and 6 submarkets by application - discover that industry's prospects, finding promising technology areas for investments and revenues
  • Revenue forecast to 2024 for the leading 13 national markets - US, Japan, Germany, France, the UK, Italy, Spain, Brazil, Russia, India, China, Mexico, South Korea and Rest of the World
  • Assess 10 leading companies in the pain management devices market - hear about products, results and strategies including recent activities and outlook.
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market
  • Opinions from our survey, seeing interviews with industry authorities.

You will find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the pain management devices market and leading companies. You will find data, trends and predictions. Please order our report now.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Pain Management Devices Market Overview
  • 1.2. Global Pain Management Devices Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Reports
  • 1.10. About Visiongain

2. An Introduction to Pain and Pain Management

  • 2.1. Pain: A Sensory And Emotional Phenomenon
    • 2.1.1. Pain: A Short History
    • 2.1.2. Pain Pathways And The Origin Of Pain
  • 2.2. The World Health Organisation (WHO) Pain Ladder
    • 2.2.1. Classification Of Pain
      • 2.2.1.1. Acute Pain
      • 2.2.1.2. Chronic Pain
  • 2.3. The Psychosocial Effects Of Chronic Pain
    • 2.3.1. Chronic Cancer Pain
    • 2.3.2. Neuropathic Pain
    • 2.3.3. Identifying Neuropathic Pain
  • 2.4. The Neurochemistry Of Pain
    • 2.4.1. Prostaglandins
    • 2.4.2. Opioids
  • 2.5. Pain Management - A Brief Overview
  • 2.6. Pain Management Drugs
    • 2.6.1. The Use Of Opioids In Pain Management
    • 2.6.2. OTC Pain Relievers
  • 2.7. Pain Management Devices
    • 2.7.1. Radiofrequency Ablation Devices
    • 2.7.2. Analgesic Pumps
      • 2.7.2.1. Types Of Infusion
      • 2.7.2.2. Advantages And Disadvantages Of Infusion Pumps
    • 2.7.3. Intradiscal Electrothermal Therapy
    • 2.7.4. Neurostimulation
      • 2.7.4.1. Spinal Cord Stimulation
      • 2.7.4.2. Deep Brain Stimulation
      • 2.7.4.3. Occipital Nerve Stimulation
    • 2.7.5. Microcurrent Electrical Neuromuscular Stimulation
    • 2.7.6. Transcutaneous Electrical Nerve Stimulation
  • 2.8. Medical Devices Classification Systems
    • 2.8.1. The US Medical Devices Classification System
    • 2.8.2. The EU Medical Devices Classification System
  • 2.9. Regulation Of Medical Devices
    • 2.9.1. The US Approval And Regulation System
    • 2.9.2. The EU Approval And Regulation System
      • 2.9.2.1. Post-Marketing Surveillance In The EU
  • 2.10. Market Definition

3. The Global Pain Management Devices Market: By Device Type, 2014-2024

  • 3.1. The Global Pain Management Market In 2013
  • 3.2. Pain Management Devices: Global Market Overview
    • 3.2.1. The Global Pain Management Devices Market In 2013
    • 3.2.2. Global Pain Management Devices: Market Forecast 2014-2024
    • 3.2.3. Changing Market Shares By Sector 2014-2024
  • 3.3. Analgesia Infusion Pumps Market 2014-2024
    • 3.3.1. Intrathecal Drug Delivery Systems
    • 3.3.2. Patient Controlled Analgesia
      • 3.3.2.1. Costs And Benefits Of PCA Pumps
      • 3.3.2.2. PCA Pumps: Leading Products, 2014
    • 3.3.3. Analgesia Infusion Pumps: Market Forecast 2014-2024
  • 3.4. Spinal Cord Stimulation Market 2014-2024
    • 3.4.1. Spinal Cord Stimulation: Leading Products, 2014
    • 3.4.2. Spinal Cord Stimulation For Pain Management: Market Forecast 2014-2024
  • 3.5. Radiofrequency Ablation Market 2014-2024
    • 3.5.1. Radiofrequency Ablation for Pain Management: Leading Products, 2014
    • 3.5.2. Radiofrequency Ablation for Pain Management: Market Forecast 2014-2024
  • 3.6. Intradiscal Electrothermal Therapy 2014-2024
    • 3.6.1. Intradiscal Electrothermal Therapy for Pain Management: Market Forecast 2014-2024
  • 3.7. Transcutaneous Electrical Nerve Stimulation 2014-2024
    • 3.7.1. Transcutaneous Electrical Nerve Stimulation: Leading Products, 2014
    • 3.7.2. Transcutaneous Electrical Nerve Stimulation For Pain Management: Market Forecast 2014-2024
  • 3.8. Microcurrent Electrical Neuromuscular Stimulation 2014-2024
    • 3.8.1. Microcurrent Electrical Neuromuscular Stimulation For Pain Management: Market Forecast 2014-2024
  • 3.9. Other Pain Management Devices 2014-2024
    • 3.9.1. Occipital Nerve Stimulation As A Pain Management Therapy
    • 3.9.2. Deep Brain Stimulation As A Pain Management Therapy
    • 3.9.3. Other Pain Management Devices: Market Forecast 2014-2024

4. The Global Pain Management Devices Market: By Application, 2014-2024

  • 4.1. Chronic Pain: Variable Causes And Related Conditions
  • 4.2. Pain Management Devices: Applications and Uses
    • 4.2.1. Pain Management Devices Market By Application In 2013
    • 4.2.2. Global Pain Management Devices By Application: Market Forecast 2014-2024
    • 4.2.3. Changing Market Shares By Application 2014-2024
  • 4.3. Musculoskeletal Pain Management Devices Market 2014-2024
    • 4.3.1. Musculoskeletal Pain Management Devices: Leading Products, 2014
    • 4.3.2. Musculoskeletal Pain Management Devices: Market Forecast 2014-2024
  • 4.4. Cancer Pain Management Devices Market 2014-2024
    • 4.4.1. Cancer Pain Management Devices: Leading Products, 2014
    • 4.4.2. Cancer Pain Management Devices: Market Forecast 2014-2024
  • 4.5. Migraine and Facial Pain Management Devices Market 2014-2024
    • 4.5.1. Migraine Relieving Techniques
    • 4.5.2. Migraine Pain Management Devices: Leading Products, 2014
    • 4.5.3. Migraine And Facial Pain Management Devices: Market Forecast 2014-2024
  • 4.6. Neuropathic Pain Management Devices Market 2014-2024
    • 4.6.1. Neuropathic Pain Management Devices: Leading Products, 2014
    • 4.6.2. Neuropathic Pain Management Devices: Market Forecast 2014-2024
  • 4.7. Surgical And Trauma Pain Management Devices Market 2014-2024
    • 4.7.1. Surgical And Trauma Pain Management Devices: Leading Products, 2014
    • 4.7.2. Surgical And Trauma Pain Management Devices: Market Forecast 2014-2024
  • 4.8. The Market For Other Pain Management Devices 2014-2024
    • 4.8.1. The Market For Other Pain Management Devices: Market Forecast 2014-2024

5. Leading National Pain Management Devices Markets 2014-2024

  • 5.1. The Pain Management Devices Market By Region
    • 5.1.1. The Global Distribution Of Pain Management Devices In 2013
  • 5.2. Leading National Markets: Forecast, 2014-2024
    • 5.2.1. Changing Market Shares By Region, 2014-2024
  • 5.3. Regional Pain Management Devices Markets: Analysis and Forecasts, 2014-2024
  • 5.4. United States: The Largest Pain Management Devices Market
  • 5.5. The EU5 Markets
    • 5.5.1. EU5 Markets: Changing Market Shares by Country, 2014-2024
    • 5.5.2. Germany: Fiscal Austerity Programs And Spending Cuts Impacting Market Growth
    • 5.5.3. France: Price Reductions And Lowering Consumption Are Concerns For Market Growth
    • 5.5.4. UK: Private Patient Income Will Help To Offset Low Funding Levels
    • 5.5.5. Italy: Restrictions On The Use Of Analgesic Drugs To Help Boost Pain Devices
    • 5.5.6. Spain: Rationalisation Of Health And Pharmaceutical Expenditure Limiting Market Growth
  • 5.6. China: Shifting Technological Landscape Will Drive Market Growth
  • 5.7. Japan: An Ageing Population Coupled With The Fear Of Opioid Addiction Will Stimulate Pain Devices Uptake
  • 5.8. India: Rising Pain Incidence And Improving Socio-Economic Conditions
  • 5.9. South Korea: Universal Healthcare Coverage And Government Investment Fuelling Market Growth
  • 5.10. Russia: Improving Market Penetration For Pain Devices
  • 5.11. Brazil: Inadequate Infrastructure Limiting Expansion
  • 5.12. Mexico: Heavy Regulation Of Opioid Use To Strengthen Device Uptake
  • 5.13. Rest Of The World

6. Leading Companies in the Pain Management Devices Market, 2014

  • 6.1. Pain Management Devices - A Diversified Market
  • 6.2. BioDelivery Sciences International (BDSI)
    • 6.2.1. BDSI - The BEMA Technology Platform
    • 6.2.2. BDSI: Historical Revenue Analysis, 2009-2013
  • 6.3. Boston Scientific
    • 6.3.1. Boston Scientific: Revenue Analysis, 2013
    • 6.3.2. Boston Scientific - Precision And Precision Spectra Spinal Cord Stimulation Systems
    • 6.3.3. GUIDE DBS And Enspire DBS Systems - Intelect Medical/Boston Scientific
  • 6.4. Cephalon (Teva Pharmaceuticals)
    • 6.4.1. Cephalon's Pain Management Products
      • 6.4.1.1. Actiq - Cephalon's Therapy For Cancer Pain
  • 6.5. DJO Global (Empi Inc)
    • 6.5.1. Empi Inc
    • 6.5.2. Empi's Electrotherapy Products
    • 6.5.3. Empi's Iontophoresis Patch Systems
  • 6.6. Endo Pharmaceuticals
    • 6.6.1. Endo Pharmaceuticals: Historical Revenue Analysis, 2011-2013
    • 6.6.2. Endo Pharmaceuticals Pain Management - Lidoderm
  • 6.7. Hospira
    • 6.7.1. Hospira: Historical Revenue Analysis, 2009-2013
    • 6.7.2. Hospira - LifeCare PCA Infusion System
  • 6.8. Kimberly-Clark Health Care
    • 6.8.1. Kimberly-Clark: Revenue Analysis
    • 6.8.2. Kimberly-Clark's Cooled Radiofrequency System for Chronic Pain Relief
  • 6.9. Medtronic
    • 6.9.1. Medtronic: Historical Revenue Analysis, 2013-2014
    • 6.9.2. Medtronic Pain Management Products
      • 6.9.2.1. RestoreSensor Neurostimulator
      • 6.9.2.2. RestoreUltra Neurostimulator
      • 6.9.2.3. SynchroMed II Drug Pump
  • 6.10. Pain Management Technologies Inc
    • 6.10.1. Pain Management Technologies Inc's Products
  • 6.11. St Jude Medical
    • 6.11.1. St Jude Medical: Historical Revenue Analysis, 2009-2013
    • 6.11.2. St Jude Medical: Pain Management Products
    • 6.11.3. Axium Neurostimulator System - SJM and Spinal Modulation

7. Pain Management Devices: R&D Pipeline 2014-2024

  • 7.1. Peripheral Nerve Stimulation - Pipeline Products
    • 7.1.1. Altius System High Frequency Nerve Block (Neuros Medical)
    • 7.1.2. MicroStim System (MicroTransponder Inc)
    • 7.1.3. Senza SCS System (Nevro Corporation)
  • 7.2. Analgesic Infusion Systems - Pipeline Products
    • 7.2.1. Programmable Implantable DDS (Palyon Medical Corporation)
    • 7.2.2. Zalviso (AcelRx Pharmaceuticals)
  • 7.3. Occipital Nerve Stimulation - Pipeline Products
    • 7.3.1. Precision System (Boston Scientific)
  • 7.4. Radiofrequency Ablation - Pipeline Products
    • 7.4.1. Intracept (Relievant Medsystems Inc)

8. Qualitative Analysis of the Pain Management Devices Market, 2014-2024

  • 8.1. SWOT Analysis Of The Pain Management Devices Market, 2014-2024
    • 8.1.1. Strengths
      • 8.1.1.1. Cost Effectiveness: A Central Driver For Growth
      • 8.1.1.2. Positive Side Effect Profile Of Pain Management Devices Compared With Pain Relieving Drugs
    • 8.1.2. Weaknesses
      • 8.1.2.1. Short Term Pain Relief
      • 8.1.2.2. Mechanisms Of Action Not Fully Understood
      • 8.1.2.3. Lack Of Evidence To Support The Efficacy And Safety Of Some Therapies
      • 8.1.2.4. Devices Failing In Clinical Trials
      • 8.1.2.5. Education In Pain Management Is A Key Unmet Need
    • 8.1.3. Opportunities
      • 8.1.3.1. Expanding Disease Indications Driving Neurostimulation for Pain Relief
      • 8.1.3.2. The Potential Of Personalised Medicine
      • 8.1.3.3. Expansion Into Emerging Markets
      • 8.1.3.4. Ageing Population - Growth Driver For Pain Management
    • 8.1.4. Threats
      • 8.1.4.1. Increasing Regulatory And Pricing Scrutiny
      • 8.1.4.2. Medical Device Excise Tax: A Drain On Innovation?
      • 8.1.4.3. Inadequate Reimbursement Levels Limits Potential Of Pain Devices
  • 8.2. Porter's Five Force Analysis Of The Pain Management Device Market
    • 8.2.1. Threat Of Substitutes: High
    • 8.2.2. Power Of Suppliers: Medium
    • 8.2.3. Rivalry Among Competitors: Medium
    • 8.2.4. Bargaining Power Of Buyers: High
    • 8.2.5. Threat Of New Entrants: Medium

9. Expert Opinions

  • 9.1. Interview With Dr Deepak Kotak, Executive Vice President, BioElectronics Corporation
    • 9.1.1. Pain Management Devices: Market Stratification And Brief History
    • 9.1.2. On The Direct And Related Costs Of Pain And Pain Management
    • 9.1.3. BioElectronics' Products - FDA Approvals And The Quest For OTC Status
    • 9.1.4. BioElectronic's Product Distribution Partnerships And Entry Into The Advanced Wound Care Markets
    • 9.1.5. On The Future Plans For Product Launch
    • 9.1.6. The Issue Of Efficacy And Healthcare Economics And Their Impact On Pain Management Devices
    • 9.1.7. On Future Technological Developments - Vagal Nerve And Trigeminal Nerve Stimulation
    • 9.1.8. On The Future Challenges And Opportunities Facing Pain Management Devices Over The Next Decade
  • 9.2. Interview With Penney Cowan, Chief Executive Officer, American Chronic Pain Association
    • 9.2.1. On The Current State Of The Pain Management Devices Market
    • 9.2.2. Socio-Political Influences On Pain Management Device And The Current Trends In The Market
    • 9.2.3. ACPA's Role In Patient Empowerment And Pain Management
    • 9.2.4. ACPA's Corporate Strategy And Future Plans
    • 9.2.5. On The Misconceptions Surrounding Pain And Pain Management
    • 9.2.6. On Factors That Will Affect Future Technology Developments In Pain Management
    • 9.2.7. Interdisciplinary Pain Management As An Opportunity For Market Growth

10. Conclusion

  • 10.1. Market Overview
  • 10.2. Commercial Drivers For Pain Management Devices
  • 10.3. Neuromodulation Looks Set For High Growth
  • 10.4. Rising Demand From Musculoskeletal Pain Will Drive Market Growth
  • 10.5. Leading Developers Of Pain Management Devices
  • 10.6. Growth Concentrated In The Developed Markets Of North America And Europe
  • 10.7. Future Prospects For Pain Management Devices

List of Tables

  • Table 2.1: Comparison of Acute and Chronic Pain
  • Table 2.2: Therapeutic Classes In Pain Management
  • Table 2.3: Ideal Specifications Of An Infusion Pump
  • Table 2.4: Advantages and Disadvantages of Infusion Pumps
  • Table 2.5: The US Classification of Medical Devices
  • Table 2.6: The EU Classification of Medical Devices
  • Table 3.1: The Global Pain Management Devices Market: Revenue ($m) and Market Shares (%) by Sector, 2013
  • Table 3.2: The Global Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%) by Sector, 2013-2024
  • Table 3.3: The Global Pain Management Devices Market: CAGR (%) by Sector, 2013-2018, 2018-2024, 2013-2024
  • Table 3.4: The Global Pain Management Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
  • Table 3.5: The Global Pain Management Devices Market: Market Shares (%) by Sector, 2013, 2018, 2024
  • Table 3.6: Clinical Settings Where PCA Pumps Are Used
  • Table 3.7: Advantages and Disadvantages of PCA Pumps
  • Table 3.8: PCA Pumps: Leading Products, 2014
  • Table 3.9: Analgesia Infusion Pumps Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.10: Spinal Cord Stimulation for Pain Management: Leading Products, 2014
  • Table 3.11: Spinal Cord Stimulation for Pain Management Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.12: Radiofrequency Ablation for Pain Management: Leading Products, 2014
  • Table 3.13: Radiofrequency Ablation for Pain Management Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.14: Intradiscal Electrothermal Therapy for Pain Management Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.15: Current Solutions: Selected TENS Products, 2014
  • Table 3.16: Transcutaneous Electrical Nerve Stimulation for Pain Management: Leading Products, 2014
  • Table 3.17: Transcutaneous Electrical Nerve Stimulation for Pain Management Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.18: Microcurrent Electrical Neuromuscular Stimulation for Pain Management Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.19: Other Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.1: Global Pain Management Devices Market: Revenue ($m) and Market Shares (%) by Application, 2013
  • Table 4.2: Global Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%) by Application, 2013-2024
  • Table 4.3: The Global Pain Management Devices Market: CAGR (%) by Application, 2013-2018, 2018-2024, 2013-2024
  • Table 4.4: The Global Pain Management Devices Market: Revenue ($m) by Application, 2013, 2018, 2024
  • Table 4.5: The Global Pain Management Devices Market: Market Share (%) by Application, 2013, 2018, 2024
  • Table 4.6: Musculoskeletal Pain Management Devices: Selected Products, 2014
  • Table 4.7: Musculoskeletal Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.8: Cancer Pain Management Devices: Selected Products, 2014
  • Table 4.9: Cancer Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.10: Migraine Pain Management Devices: Selected Products, 2014
  • Table 4.11: Migraine and Facial Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.12: Neuropathic Pain Management Devices: Selected Products, 2014
  • Table 4.13: Neuropathic Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.14: Surgical and Trauma Pain Management Devices: Selected Products, 2014
  • Table 4.15: Surgical and Trauma Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.16: Other Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.1: The Global Pain Management Devices Market: Market Size ($m) and Market Shares (%) by Region, 2013
  • Table 5.2: Global Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%) by Region, 2013-2024
  • Table 5.3: Pain Management Devices Market Forecast: CAGR (%) by Region, 2013-2018, 2018-2024, and 2013-2024
  • Table 5.4: Pain Management Devices Market Forecast: Market Shares (%) by Region, 2013, 2018, 2024
  • Table 5.5: US Pain Management Devices Market Forecast: Revenue ($m), Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.6: US Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.7: The EU5 Pain Management Devices Market Forecast: Revenue ($m), Market Share (%) and CAGR (%), 2013-2024
  • Table 5.8: The EU5 Pain Management Devices Market: Revenue ($m) and Market Share (%) by Country, 2013
  • Table 5.9: The EU5 Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%) by Country, 2013-2024
  • Table 5.10: The EU5 Pain Management Devices Market: Market Share (%) by Country, 2013, 2018, 2024
  • Table 5.11: The German Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.12: The German Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.13: The French Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.14: The French Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.15: The UK Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.16: The UK Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.17: The Italian Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.18: The Italian Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.19: The Spanish Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.20: The Spanish Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.21: The Chinese Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.22: The Chinese Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.23: The Japanese Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.24: The Japanese Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.25: The Indian Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.26: The Indian Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.27: The South Korean Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.28: The South Korean Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.29: The Russian Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.30: The Russian Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.31: The Brazilian Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.32: The Brazilian Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.33: The Mexican Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 5.34: The Mexican Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.35: The Rest of the World Pain Management Devices Market Forecast: Revenue ($m), Market Share (%) and CAGR (%), 2013-2024
  • Table 5.36: The Rest of the World Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 6.1: BioDiscovery Sciences Inc: Historical Revenue ($m, AGR%), 2009-2013
  • Table 6.2: Boston Scientific: Revenues ($m) and Revenue Shares (%) by Franchise, 2013
  • Table 6.3: Boston Scientific: Revenues ($m) and Revenue Shares (%) by Region, 2013
  • Table 6.4: Empi Inc: Selected Pain Management Products and Product Details, 2014
  • Table 6.5: Lidoderm: Historical Sales ($m, AGR%), 2011-2013
  • Table 6.6: Hospira: Historical Revenue ($m, AGR%), 2009-2013
  • Table 6.7: Hospira: Revenues ($m) and Revenue Shares (%) by Franchise, 2013
  • Table 6.8: Kimberly-Clark: Revenues ($m) and Revenue Shares (%) by Business Segment, 2013
  • Table 6.9: Kimberly-Clark: Revenues ($m) and Revenue Shares (%) by Region, 2013
  • Table 6.10: Kimberly-Clark's Cooled RF Pain Management Systems: Selected Products and Product Details, 2014
  • Table 6.11: Medtronic: Revenues ($bn) and Revenue Shares (%) by Franchise, 2013/14
  • Table 6.12: Pain Management Technologies Inc: Selected Products, 2014
  • Table 6.13: St Jude Medical: Historical Revenue ($m, AGR%), 2009-2013
  • Table 6.14: St Jude Medical: Revenues ($m) and Revenue Shares (%) by Franchise, 2013
  • Table 8.1: Pain Management Devices: Market Drivers and Restraints 2014-2024
  • Table 8.2: SWOT Analysis of the Pain Management Devices Market, 2014-2024
  • Table 8.3: Global Population Forecast: Total Population (bn, CAGR %) and Over-65 Population (bn, CAGR%), 2012, 2015, 2018, and 2023
  • Table 10.1: Pain Management Devices: Market Forecast ($m, CAGR%), 2013, 2018, 2021, 2024
  • Table 10.2: Pain Management Devices: Market Forecast ($m) by Sector, 2013, 2018, 2021, 2024
  • Table 10.3: Global Pain Management Devices: Market Shares (%) by Region, 2013, 2018, 2021, 2024

List of Figures

  • Figure 1.1: The Global Over 65 Population: Forecast (millions, AGR%), 2013-2024
  • Figure 1.2: Global Pain Management Devices Market: Segmentation By Device Type, 2014
  • Figure 1.3: Global Pain Management Devices Market: Segmentation By Application , 2014
  • Figure 2.1: Categories of Pain
  • Figure 3.1: The Global Pain Management Devices Market: Revenue ($m) by Sector, 2013
  • Figure 3.2: The Global Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.3: The Global Pain Management Devices Market: CAGR (%) by Sector, 2013-2018
  • Figure 3.4: The Global Pain Management Devices Market: CAGR (%) by Sector, 2018-2024
  • Figure 3.5: The Global Pain Management Devices Market: CAGR (%) by Sector, 2013-2024
  • Figure 3.6: The Global Pain Management Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
  • Figure 3.7: The Global Pain Management Devices Market: Market Share (%) by Sector, 2013
  • Figure 3.8: The Global Pain Management Devices Market: Market Share (%) by Sector, 2018
  • Figure 3.9: The Global Pain Management Devices Market: Market Share (%) by Sector, 2024
  • Figure 3.10: Analgesia Infusion Pumps Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.11: Spinal Cord Stimulation for Pain Management Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.12: Radiofrequency Ablation for Pain Management Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.13: Intradiscal Electrothermal Therapy for Pain Management Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.14: Transcutaneous Electrical Nerve Stimulation for Pain Management Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.15: Microcurrent Electrical Neuromuscular Stimulation for Pain Management Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.16: Other Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.1: Pain Functions Where Pain Management Devices are Utilized
  • Figure 4.2: Global Pain Management Devices Market: Revenue ($m) by Application, 2013
  • Figure 4.3: The Global Pain Management Devices Market: CAGR (%) by Application, 2013-2018
  • Figure 4.4: The Global Pain Management Devices Market: CAGR (%) by Application, 2018-2024
  • Figure 4.5: The Global Pain Management Devices Market: CAGR (%) by Application, 2013-2024
  • Figure 4.6: The Global Pain Management Devices Market: Revenue ($m) by Application, 2013, 2018, 2024
  • Figure 4.7: The Global Pain Management Devices Market: Market Shares (%) by Application, 2013
  • Figure 4.8: The Global Pain Management Devices Market: Market Shares (%) by Application, 2018
  • Figure 4.9: The Global Pain Management Devices Market: Market Shares (%) by Application, 2024
  • Figure 4.10: Musculoskeletal Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.11: Cancer Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.12: Migraine and Facial Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.13: Neuropathic Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.14: Surgical and Trauma Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.15: Other Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.1: The Global Pain Management Devices Market: Market Size ($m) by Region, 2013
  • Figure 5.2: US, EU5, China and Japan Pain Management Devices Market: Market Forecast ($m), 2013-2024
  • Figure 5.3: India, South Korea, Russia, Brazil, and Mexico Pain Management Devices Market: Market Forecast ($m), 2013-2024
  • Figure 5.4: Pain Management Devices Market Forecast: CAGR (%) by Region, 2013-2018
  • Figure 5.5: Pain Management Devices Market Forecast: CAGR (%) by Region, 2018-2024
  • Figure 5.6: Pain Management Devices Market Forecast: CAGR (%) by Region, 2013-2024
  • Figure 5.7: Pain Management Devices Market Forecast: Market Shares (%) by Region, 2013
  • Figure 5.8: Pain Management Devices Market Forecast: Market Shares (%) by Region, 2018
  • Figure 5.9: Pain Management Devices Market Forecast: Market Shares (%) by Region, 2024
  • Figure 5.10: US Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.11: The EU5 Pain Management Devices Market: Revenues ($m) by Country, 2013
  • Figure 5.12: Germany, UK, Spain, France, and Italy Pain Management Devices Market: Market Forecast ($m), 2013-2024
  • Figure 5.13: The EU5 Pain Management Devices Market: Market Shares (%) by Country, 2013
  • Figure 5.14: The EU5 Pain Management Devices Market: Market Shares (%) by Country, 2018
  • Figure 5.15: The EU5 Pain Management Devices Market: Market Shares (%) by Country, 2024
  • Figure 5.16: The German Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.17: The French Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.18: The UK Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.19: The Italian Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.20: The Spanish Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.21: The Chinese Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.22: The Japanese Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.23: The Indian Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.24: The South Korean Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.25: The Russian Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.26: The Brazilian Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.27: The Mexican Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 5.28: The Rest of the World Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 6.1: BioDiscovery Sciences Inc: Historical Revenue ($m, AGR%), 2009-2013
  • Figure 6.2: Boston Scientific: Revenue Shares (%) by Franchise, 2013
  • Figure 6.3: Boston Scientific: Revenue ($m) by Region, 2013
  • Figure 6.4: Lidoderm: Historical Sales ($m, AGR%), 2011-2013
  • Figure 6.5: Hospira: Historical Revenue ($m, AGR%), 2009-2013
  • Figure 6.6: Hospira: Revenue Shares (%) by Franchise, 2013
  • Figure 6.7: Kimberly-Clark: Revenue Shares (%) by Business Segment, 2013
  • Figure 6.8: Kimberly-Clark: Revenues ($m) by Region, 2013
  • Figure 6.9: Medtronic: Revenue Shares (%) by Franchise, 2013/14
  • Figure 6.10: St Jude Medical: Historical Revenue ($m, AGR%), 2009-2013
  • Figure 6.11: St Jude Medical: Revenue Shares (%) by Franchise, 2013
  • Figure 8.1: Global Population Forecast: Total Population (bn) and Over-65 Population (bn), 2012, 2015, 2018, and 2023
  • Figure 8.2: Porter's Five Force Analysis of the Pain Management Devices Market, 2014
  • Figure 10.1: Pain Management Devices: Market Forecast ($m), 2013, 2018, 2021, 2024
  • Figure 10.2: Pain Management Devices: Market Forecast ($m) by Sector, 2013-2024

Companies Listed

  • Abbot Laboratories
  • AcelRx Pharmaceuticals
  • Advanced Bionics Corporation
  • Advanced Neuromodulation Systems Inc
  • Atricure
  • B Braun Medical
  • Baxter International
  • BioDelivery Sciences International
  • BioElectronics Corporation
  • Biosense Webster Inc
  • Blackstone Capital Partners VLP
  • Boston Scientific
  • CareFusion
  • Cefaly Technology
  • Cephalon (Teva)
  • Cosman Medical
  • CTI Technologies
  • Current Solutions
  • Diros Technology
  • DJO Global
  • Endo Pharmaceuticals
  • eNeura Therapeutics
  • Fukuda Denshi
  • Grunenthal GMBH
  • Hong Qiangxing (Shenzhen) Electronics Limited
  • Hospira
  • Intelect Medical (a Boston Scientific company)
  • Kimberly-Clark Healthcare
  • Kunwha Pharmaceutical
  • Life Sciences Inc
  • Meda Pharmaceuticals
  • Medtronic
  • MicroTransponder Inc
  • Moog Inc
  • Neurometrix
  • Neuros Medical
  • Neurotech Group
  • Neurotherm
  • Nevro Corporation
  • Pain Management Technologies Inc
  • Philips Healthcare
  • Polyon Medical Corporation
  • Qrunenthal GMBH
  • Quintiles
  • ReAble Therapeutics Inc (DJO Global)
  • Relievant Medsystems Inc
  • Smith & Nephew
  • Smith Medical
  • Spinal Modulation Inc
  • St Jude Medical
  • Stryker Corporation
  • TTY Biopharm,
  • Watson Pharmaceuticals

Organisations Mentioned In The Report

  • Case Western Reserve University
  • International Association for the Study of Pain (IASP)
  • Mayo Clinic, Arizona, US
  • Ministry of Health and Welfare (MOHW) [South Korea]
  • National Institute for Health and Care Excellence (NICE)
  • Samueli Institute for Information Biology, US
  • The American Pain Society
  • The American Chronic Pain Association (ACPA)
  • The Centers for Medicare and Medicaid Services
  • The Centre for Devices and Radiological Health (CDRH) [FDA]
  • The Food and Drug Administration
  • The International Diabetes Federation
  • The National Headache Foundation [US]
  • The National Institute for Population and Social Security Research (IPSS) [Japan]
  • The US Society for Neuroscience (SfN)
  • The World Health Organization (WHO)
  • University of Texas, Dallas
  • US Census Bureau
Back to Top